Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
نویسنده
چکیده
One of the most important characteristics of systemic autoimmune diseases, including idiopathic inflammatory myopathies (IIM), is the immune response to self-antigens manifested by the production of autoantibodies that recognize a variety of cytoplasmic and nuclear antigens. In the last 40 years, autoantibodies of patients with IIM have been investigated; however, some of the fundamental questions related to these antibodies remain unresolved (1). Indirect immunofluorescence (IIF), in which HEp-2 cells are used as a substrate, is considered the gold standard for detecting antinuclear antibodies (ANA’s) in autoimmune rheumatic diseases. Using this method, specific antibodies that occur exclusively in these diseases were present in a great proportion of patients with myositis (50–80%) (2). It is important to note that patients with myositis more frequently have high titers of these antibodies than patients with overlap syndromes, and low titers usually are present in patients with myopathies associated with neoplasia. In contrast, these autoantibodies are usually absent in patients with inclusion body myositis, dystrophies, and other non-autoimmune myopathies. In general, even though the diagnostic value of these autoantibodies has been limited, they are useful as diagnostic markers since they closely correlate with certain clinical manifestations of disease and help identify clinical subgroups and to know about the prognosis of the IIM. Idiopathic inflammatorymyopathies has twomajor types of autoantibody groups: (1) those found primarily in patients suffering from polymyositis (PM) or dermatomyositis (DM) are known as myositis-specific autoantibodies (MSAs); these are not observed in other diseases of connective tissue and are almost completely absent in patients with muscular dystrophies and (2) those that appear in myositis overlap syndromes and in other connective tissue diseases, which correlate with certain clinical and/or pathophysiological conditions of myositis, are known as myositis-associated autoantibodies (MAAs) (3).
منابع مشابه
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
Autoantibodies targeting intracellular proteins involved in key processes are detected in patients with idiopathic inflammatory myopathies. These myositis-specific autoantibodies have been increasingly demonstrated to correlate with distinct clinical phenotypes within the myositis spectrum. This review highlights the clinical associations of the myositis-specific autoantibodies, with particular...
متن کاملsignificance of myositis - specific and myositis - associated autoantibodies
Autoantibodies to various cellular constituents are detected in the sera of patients with idiopathic inflammatory myopathy (IIM). These autoantibodies are closely associated with characteristic clinical manifestations of the diseases. Therefore, autoantibodies give us much information in clinical diagnosis, classification, prediction of prognosis and choice of treatment in patients with IIM. Du...
متن کاملRare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
Idiopathic inflammatory myopathies are systemic, chronic autoimmune diseases characterized by symmetrical, proximal muscle weakness. Homogeneous groups present with similar symptoms. The response to therapy and prognosis could be facilitated by myositis-specific autoantibodies, and in this way, give rise to immunoserological classification. The myositis-specific autoantibodies are directed agai...
متن کاملIdiopathic Inflammatory Myopathies: Association with Overlap Myositis and Syndromes: Classification, Clinical Characteristics, and Associated Autoantibodies
Idiopathic inflammatory myopathies (IIM) are traditionally identified as a group of disorders that target skeletal muscle due to autoimmune dysfunction. The IIM can be divided into subtypes based on certain clinical characteristics, and several classification schemes have been proposed. The predominant diagnostic criteria for IIM is the Bohan and Peter criteria, which subdivides IIM into primar...
متن کاملAutoantibodies in Idiopathic Inflammatory Myopathies
Autoimmune response to nuclear and cytoplasmic autoantigens is detected in about 60-80% of patients affected with idiopathic inflammatory myositis such as polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM). Some of the serum autoantibodies are shared with other autoimmune diseases (myositis-associated antibodies MAA) and some of them are unique to myositis (myositis-speci...
متن کامل